Ospedale di Belcolle

Recent papers from Ospedale di Belcolle

1. Anti-Drug Antibodies in Patients with Fabry Disease Treated with Agalsidase-Alpha or -Beta: A Retrospective Italian Multicenter StudyCells · 2026
2. Baveno VI criteria validation and development of a new non-invasive strategy for varices rule-out in patients with HCC (SAPHE-R: Stiffness, ALBI, Platelets, HEpatocellular carcinoma Rule)Hepatology · 2026
3. Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real‐world studyCancer · 2026
4. Minicrush or T-Stenting and Minimal Protrusion in Complex Coronary Bifurcation Lesions: The Multicenter TREX RegistryCirculation Cardiovascular Interventions · 2026
5. Major salivary gland carcinomas: A 21-center cohort study of 892 patients with external validation of the UICC 9th edition n-classificationOral Oncology · 2026
6. Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-ImmunotherapyCancers · 2026
7. A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney diseaseFrontiers in Pharmacology · 2026
8. Prognostic stratification in MDS/MPN syndromes other than CMML: an Italian multicenter real-world studyClinical and Experimental Medicine · 2026
9. Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 − metastatic breast cancer treated with CDK4/6 inhibitorsEuropean Journal of Cancer · 2026
10. Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trialBritish Journal of Haematology · 2026
11. Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World SettingInternational Journal of Cancer · 2026
12. Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and DurvalumabInternational Journal of Cancer · 2026
13. Interplay of Biological Treatment and Psychological Features in Patients with Psoriasis: A Real-Life Prospective StudyDermatology Practical & Conceptual · 2026
14. Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life StudyAmerican Journal of Therapeutics · 2026
15. Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real‐Life Survey Within the Italian Chronic Myeloid Leukemia NetworkEuropean Journal Of Haematology · 2026
16. Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyAdvances in Therapy · 2026
17. Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026
18. Rapid improvement of nasal obstruction after treatment with a non-vasoconstrictive osmotic nasal spray: A prospective observational studyAmerican Journal of Otolaryngology · 2026
19. First Identification of HEV Subtype 3i in Human Hepatitis E Cases in Central ItalyViruses · 2026
20. Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et alJournal of Psoriasis and Psoriatic Arthritis · 2026